GW&K Investment Management LLC grew its holdings in shares of LHC Group, Inc. (NASDAQ:LHCG) by 12.9% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 349,817 shares of the health services provider’s stock after buying an additional 40,100 shares during the period. GW&K Investment Management LLC’s holdings in LHC Group were worth $39,725,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors and hedge funds have also added to or reduced their stakes in LHCG. Synovus Financial Corp raised its holdings in shares of LHC Group by 130.8% during the third quarter. Synovus Financial Corp now owns 300 shares of the health services provider’s stock valued at $34,000 after buying an additional 170 shares during the last quarter. Tower Research Capital LLC TRC bought a new stake in shares of LHC Group during the second quarter valued at approximately $39,000. Security National Trust Co. bought a new stake in shares of LHC Group during the second quarter valued at approximately $120,000. Quest Capital Management Inc. ADV bought a new stake in shares of LHC Group during the third quarter valued at approximately $147,000. Finally, BB&T Securities LLC bought a new stake in shares of LHC Group during the third quarter valued at approximately $204,000. 90.90% of the stock is currently owned by institutional investors.
NASDAQ:LHCG traded up $0.93 during midday trading on Friday, hitting $126.36. 185,000 shares of the stock were exchanged, compared to its average volume of 236,717. The company has a market capitalization of $3.91 billion, a price-to-earnings ratio of 35.59, a P/E/G ratio of 2.05 and a beta of 0.79. The business has a 50-day moving average price of $115.07 and a two-hundred day moving average price of $117.39. LHC Group, Inc. has a one year low of $88.18 and a one year high of $136.67. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.16.
A number of research firms have recently weighed in on LHCG. UBS Group lifted their price target on LHC Group from $133.00 to $136.00 and gave the company a “buy” rating in a report on Monday, September 23rd. Stephens initiated coverage on LHC Group in a report on Monday, October 21st. They set an “overweight” rating and a $132.00 target price on the stock. Oppenheimer boosted their target price on LHC Group from $125.00 to $146.00 and gave the stock an “outperform” rating in a report on Friday, August 9th. Deutsche Bank initiated coverage on LHC Group in a report on Monday, September 16th. They set a “buy” rating and a $145.00 target price on the stock. Finally, Zacks Investment Research raised LHC Group from a “hold” rating to a “buy” rating and set a $124.00 target price on the stock in a report on Thursday, September 19th. Four research analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. LHC Group has an average rating of “Buy” and a consensus target price of $130.18.
LHC Group Company Profile
LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.
Recommended Story: What is Cost of Debt?
Want to see what other hedge funds are holding LHCG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LHC Group, Inc. (NASDAQ:LHCG).
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.